Contact Us

DESTINATION NEWS

NIP Group's eStar FPS Division Claims 2024 WCG CrossFire Championship

Sep 11, 2024

JAKARTA,Indonesia,Sept. 10,2024-- In a thrilling display of skill and teamwork,eStar Gaming (eStar) \'s FPS division,representing the NIP Group,stormed to victory at the 2024 World Cyber Games (WCG) C

ChipMOS REPORTS 15.4% YoY GROWTH IN AUGUST 2024 REVENUE, UP 2.5% MoM

Sep 11, 2024

HSINCHU,Sept. 10,2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider o

Updated Data from Phase II Clinical Trial of Iruplinalkib Tablets (Qixinke®) Presented at World Conference on Lung Cancer 2024

Sep 11, 2024

JINAN,China,Sept. 10,2024-- During the World Conference on Lung Cancer (WCLC) held from September 7-10,2024,in San Diego,California,updated findings from the Phase II clinical trial (INTELLECT study)

Vertilas InP VCSEL product portfolio presented at CIOE 2024 in Shenzhen, China

Sep 11, 2024

SHENZHEN,China,Sept. 10,2024-- Vertilas GmbH invites you to join our team at Booth 4D021+4D022 during the China International Optoelectronic Exposition (CIOE) 2024 in Shenzhen on 11-13 September 2024

Hollyland Elevates Wireless Communications for Large-Scale Film and TV Productions

Sep 11, 2024

Meets the need for stable and seamless communication on large film sets Supports up to 20 full-duplex wireless headsets

Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024

Sep 11, 2024

Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer,independent of PD-L1

1 ... 165 166 167 168 169 170 171 ... 232